212 related articles for article (PubMed ID: 37871305)
1. Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency.
Soukup AA; Bresnick EH
Blood Adv; 2023 Dec; 7(24):7564-7575. PubMed ID: 37871305
[TBL] [Abstract][Full Text] [Related]
2. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl T; Lunzer V; Greil R; Namberger K; Hartmann TN
Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
[TBL] [Abstract][Full Text] [Related]
3. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
4. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
[TBL] [Abstract][Full Text] [Related]
5. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
[TBL] [Abstract][Full Text] [Related]
6. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
Steinberg M; Silva M
Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
[TBL] [Abstract][Full Text] [Related]
7. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
Ramirez P; Rettig MP; Uy GL; Deych E; Holt MS; Ritchey JK; DiPersio JF
Blood; 2009 Aug; 114(7):1340-3. PubMed ID: 19571319
[TBL] [Abstract][Full Text] [Related]
8. Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100.
Alt C; Yuan S; Wu F; Stankovich B; Calaoagan J; Schopies S; Wu JY; Shen J; Schneider D; Zhu Y; Zhao XY; Lippow SM; Bauzon M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1475-1485. PubMed ID: 31163266
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor.
Fadini GP; Fiala M; Cappellari R; Danna M; Park S; Poncina N; Menegazzo L; Albiero M; DiPersio J; Stockerl-Goldstein K; Avogaro A
Diabetes; 2015 Aug; 64(8):2969-77. PubMed ID: 25804941
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP
Leukemia; 2015 Jun; 29(6):1366-78. PubMed ID: 25578474
[TBL] [Abstract][Full Text] [Related]
11. Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization.
Chen C; Song X; Ma S; Wang X; Xu J; Zhang H; Wu Q; Zhao K; Cao J; Qiao J; Sun X; Li D; Zeng L; Li Z; Xu K
Int J Hematol; 2015 Jan; 101(1):5-12. PubMed ID: 25315193
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major.
Yannaki E; Karponi G; Zervou F; Constantinou V; Bouinta A; Tachynopoulou V; Kotta K; Jonlin E; Papayannopoulou T; Anagnostopoulos A; Stamatoyannopoulos G
Hum Gene Ther; 2013 Oct; 24(10):852-60. PubMed ID: 24001178
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
Di Giacomo F; Lewandowski D; Cabannes E; Nancy-Portebois V; Petitou M; Fichelson S; Romeo PH
Haematologica; 2012 Apr; 97(4):491-9. PubMed ID: 22180429
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
[TBL] [Abstract][Full Text] [Related]
15. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
Karpova D; Rettig MP; Ritchey J; Cancilla D; Christ S; Gehrs L; Chendamarai E; Evbuomwan MO; Holt M; Zhang J; Abou-Ezzi G; Celik H; Wiercinska E; Yang W; Gao F; Eissenberg LG; Heier RF; Arnett SD; Meyers MJ; Prinsen MJ; Griggs DW; Trumpp A; Ruminski PG; Morrow DM; Bonig HB; Link DC; DiPersio JF
J Clin Invest; 2019 May; 129(7):2745-2759. PubMed ID: 31085833
[TBL] [Abstract][Full Text] [Related]
16. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
[TBL] [Abstract][Full Text] [Related]
17. Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.
Uchida N; Bonifacino A; Krouse AE; Metzger ME; Csako G; Lee-Stroka A; Fasano RM; Leitman SF; Mattapallil JJ; Hsieh MM; Tisdale JF; Donahue RE
Exp Hematol; 2011 Jul; 39(7):795-805. PubMed ID: 21549175
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and mobilization of hematopoietic precursors.
Rettig MP; Ramirez P; Nervi B; DiPersio JF
Methods Enzymol; 2009; 460():57-90. PubMed ID: 19446720
[TBL] [Abstract][Full Text] [Related]
19. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
Uy GL; Rettig MP; Cashen AF
Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
[TBL] [Abstract][Full Text] [Related]
20. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
Christopher MJ; Liu F; Hilton MJ; Long F; Link DC
Blood; 2009 Aug; 114(7):1331-9. PubMed ID: 19141863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
